Notify Therapeutics

Notify Therapeutics is a leading biotechnology company dedicated to developing innovative solutions to address the challenges of infertility. Notify focuses on the early development of ovarian follicles to assist women with infertility who cannot benefit from current standard hormone therapies. Notify is developing a first-of-its-kind drug that induces factors regulating the NRF2 pathway within cells; NRF2 is the main driver of follicle activation and a signaling pathway that promotes follicle survival and growth in response to extracellular signals.